KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer.

MLA

Mukherjee, Neelam, et al. “KLRF1, a Novel Marker of CD56bright NK Cells, Predicts Improved Survival for Patients with Locally Advanced Bladder Cancer.” Cancer Medicine, vol. 12, no. 7, Apr. 2023, pp. 8970–80. EBSCOhost, https://doi.org/10.1002/cam4.5579.

APA

Mukherjee, N., Ji, N., Tan, X., Chen, C., Noel, O. D. V., Rodriguez, P. M., Lin, C., Alonzo, D. G., Huang, T. H., & Svatek, R. S. (2023). KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer. Cancer Medicine, 12(7), 8970–8980. https://doi.org/10.1002/cam4.5579

Chicago

Mukherjee, Neelam, Niannian Ji, Xi Tan, Chun‐Liang Chen, Onika D. V. Noel, Padron, Maria Rodriguez, Chun‐Lin Lin, David G. Alonzo, Tim H. Huang, and Robert S. Svatek. 2023. “KLRF1, a Novel Marker of CD56bright NK Cells, Predicts Improved Survival for Patients with Locally Advanced Bladder Cancer.” Cancer Medicine 12 (7): 8970–80. doi:10.1002/cam4.5579.